Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address ...

An illustration of two blue-hued T cells next to one another against a dark background. Regulatory T cells, or T regs, make up the basis for a slew of biotech companies working to treat immunological ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of infection, these so-called Tregs restrain the immune system to ensure it ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance.

Orca-T demonstrated superior cGVHD-free survival and lower nonrelapse mortality compared to standard allo-HSCT in the Precision-T trial. The immunotherapy utilizes a mix of hematopoietic stem cells, ...

Researchers have published the first description of the role of the ZFP36 family of RNA binding proteins in regulatory T cells (Tregs). Tregs are key to maintaining balance in the immune system and ...

The FDA has granted Coya 302 a fast-track designation for ALS, according to a press release from Coya Therapeutics. “ALS is a ...